Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Wistar Institute discloses EBNA-1 inhibitors

Dec. 2, 2016

Kalyra Pharmaceuticals patents EGFR inhibitors

Dec. 2, 2016

Boehringer Ingelheim prepares and tests IGF-1R inhibitors

Dec. 1, 2016

Roche patent describes TLR7 agonists for HBV infections

Dec. 1, 2016

Selvita reports PFKFB inhibitors in patent

Dec. 1, 2016

Australian institutes describe IRAP inhibitors

Dec. 1, 2016

Tangrun Pharmaceuticals patents agents for HCV infection

Dec. 1, 2016

Hangzhou Hertz Pharmaceutical develops BTK inhibitors

Nov. 30, 2016

Roche discloses HTRA1 inhibitors

Nov. 30, 2016

Ariad Pharmaceuticals patents EGFR and/or HER2 mutant inhibitors

Nov. 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...